BRIEF published on 11/12/2024 at 08:05, 9 days 6 hours ago OHB SE Reports Mixed Financial Results for First Nine Months of 2024 Growth Strategy Financial Results Order Backlog OHB SE Takeover Offer
PRESS RELEASE published on 11/12/2024 at 08:00, 9 days 6 hours ago OHB SE: 9-month interim report 2024 OHB SE reports 9-month interim results for 2024 with EUR 72.5 million Adjusted EBITDA, 22% order backlog growth, and successful takeover offer completion by Orchid Lux HoldCo EBITDA Order Backlog OHB SE Takeover Offer 9-month Interim Report
BRIEF published on 08/28/2024 at 09:06, 2 months 24 days ago NuWays AG Issues Sell Recommendation for OHB SE OHB SE Free Float Share Transfer KKR Acquisition Sell Recommendation
PRESS RELEASE published on 08/28/2024 at 09:01, 2 months 24 days ago Original-Research: OHB SE (von NuWays AG): SELL NuWays AG updates research on OHB SE, recommending to sell due to pending takeover by KKR and Fuchs Family. Details of the share transfer, new shareholder structure, and delisting discussed NuWays AG OHB SE Shareholder Structure Takeover KKR
BRIEF published on 08/27/2024 at 19:35, 2 months 24 days ago KKR Completes Regulatory Approvals for OHB Investment Investment Delisting KKR OHB Space Solutions
PRESS RELEASE published on 08/27/2024 at 19:30, 2 months 24 days ago KKR has received all regulatory approvals for its investment in OHB KKR completes investment in OHB SE after regulatory approvals. OHB to delist from the stock exchange. Fuchs family remains majority shareholder Investment OHB SE Delisting KKR Fuchs Family
BRIEF published on 08/09/2024 at 09:11, 3 months 12 days ago NuWays AG Reiterates "Sell" Rating for OHB SE Amidst Pending FDI Approval NuWays AG OHB SE KKR Takeover FDI Approval Sell Rating
PRESS RELEASE published on 08/09/2024 at 09:06, 3 months 12 days ago Original-Research: OHB SE (von NuWays AG): SELL Research report on OHB SE by NuWays AG discusses the imminent deal closing with focus on Belgium's FDI approval, potential outcomes, and investor recommendations NuWays AG OHB SE Research Report Deal Closing Belgium FDI Approval
BRIEF published on 08/08/2024 at 08:05, 3 months 13 days ago OHB SE Reports Record Revenues for First Half of 2024 Revenues Half-year Report OHB SE Takeover Aerospace
PRESS RELEASE published on 08/08/2024 at 08:00, 3 months 13 days ago OHB SE: 6-month interim report 2024 OHB SE announces record total revenues of EUR 470 million and stable order backlog. Successful projects in SPACE SYSTEMS and AEROSPACE segments. Updated financial figures for the first six months of 2024 Revenues Financial Report Order Backlog OHB SE Segment Performance
Published on 11/21/2024 at 14:00, 17 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 17 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 17 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 13:30, 47 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 12:35, 1 hour 41 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 2 hours 2 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 19 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 57 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 32 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 32 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
